Editorial: better outcomes for Crohn's disease-more than just the drugs?

Samantha J Benson-Pope¹, Richard B Gearry^{1

2}

Affiliations

¹ Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
² Department of Medicine, University of Otago, Christchurch, New Zealand.

Editorial

Samantha J Benson-Pope et al. Aliment Pharmacol Ther. 2020 Jan.

. 2020 Jan;51(1):167-168.

doi: 10.1111/apt.15543.

Samantha J Benson-Pope¹, Richard B Gearry^{1

2}

¹ Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
² Department of Medicine, University of Otago, Christchurch, New Zealand.

No abstract available

Comment on

Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort.
Rahman A, Jairath V, Feagan BG, Khanna R, Shariff SZ, Allen BN, Jenkyn KB, Vinden C, Jeyarajah J, Mosli M, Benchimol E. Rahman A, et al. Aliment Pharmacol Ther. 2019 Nov;50(10):1086-1093. doi: 10.1111/apt.15511. Epub 2019 Oct 17. Aliment Pharmacol Ther. 2019. PMID: 31621934

1. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720-727.
1. Rahman A, Jairath V, Feagan BG, et al. Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort. Aliment Pharmacol Ther. 2019;50:1086-1093.
1. London R. IBD inpatient care audit - Adult report - round four 2014. 2015; https://www.rcplondon.ac.uk/projects/outputs/ibd-inpatient-care-audit-ad.... Accessed 23 September 2019.
1. Shawihdi M, Dodd S, Kallis C, et al. Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013. Aliment Pharmacol Ther. 2019;50:176-192.
1. Click B, Regueiro M. The inflammatory bowel disease medical home: from patients to populations. Inflamm Bowel Dis. 2019;1:https://doi.org/10.1093/ibd/izz062